|drug1551||Flu shot Wiki||1.00|
|drug3975||The Vie Scope laryngoscope Wiki||1.00|
|D045169||Severe Acute Respiratory Syndrome NIH||0.04|
|D018352||Coronavirus Infections NIH||0.04|
There is one clinical trial.
The current COVID-19 pandemic, this is especially since the transmission of SARS-CoV-2 is thought to occur mainly through respiratory droplets generated by coughing and sneezing, by direct contact with contaminated surfaces and because in a large number of patients COVID-19 disease may be asymptomatic. As recommended by the CDC for aerosol-generating procedures (AGP), medical personnel should be equipped with full personal protective equipment (PPE) for AGP. Therefore, it is reasonable to search for the most effective methods of intubation in those conditions.
Description: time from pick up device to the final placement tube in tracheaMeasure: time to intubation Time: 1 day
Description: A failed intubation attempt was defined as an attempt in which the trachea was not intubated, or which required more than 120 seconds to performMeasure: success of intubation Time: 1 day
Description: the number of optimization maneuvers required (re-adjustment of head position, second assistant) to aid endotracheal intubationMeasure: Number of optimalization maneuvers Time: 1 day
Description: self-reported percentage the vocal cord visualization. A 100% score is a extremely difficult procedure. A Ease of use score of 1% means that procedure is extremely easyMeasure: Procedure Ease of use Time: 1 day
Description: The POGO score describes how much glottic opening is visible. A POGO score of 100% indicates visualization of the entire glottic opening from the anterior commissure of the vocal cords to the interarytenoid notch. A POGO score of 0% corresponds with no visualization of laryngeal structures.Measure: the degree of visibility of the glottis Time: 1 day
Description: self-reported percentage the vocal cord visualization using the Cormack-Lehane grading (grade 1-4)Measure: Cormack - Lehane grade Time: 1 day
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports